1373313-86-0

Basic information

• Product Name: 1-[ (1R,2S,3R)-2,3-(O-isopropylidenedioxy)-4-[2-(ter t-butyldiphenylsilyloxy)ethyl]cyclopent-4⁽⁵⁾en]-(6-chloropurine-9-yl)
• Synonyms: 1-[ (1R,2S,3R)-2,3-(O-isopropylidenedioxy)-4-[2-(ter t-butyldiphenylsilyloxy)ethyl]cyclopent-4⁽⁵⁾en]-(6-chloropurine-9-yl)
• CAS NO: 1373313-86-0
• Molecular Weight: 575.182
• Mol File: 1373313-86-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-[ (1R,2S,3R)-2,3-(O-isopropylidenedioxy)-4-[2-(ter t-butyldiphenylsilyloxy)ethyl]cyclopent-4⁽⁵⁾en]-(6-chloropurine-9-yl)(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[ (1R,2S,3R)-2,3-(O-isopropylidenedioxy)-4-[2-(ter t-butyldiphenylsilyloxy)ethyl]cyclopent-4⁽⁵⁾en]-(6-chloropurine-9-yl)(1373313-86-0)
• EPA Substance Registry System: 1-[ (1R,2S,3R)-2,3-(O-isopropylidenedioxy)-4-[2-(ter t-butyldiphenylsilyloxy)ethyl]cyclopent-4⁽⁵⁾en]-(6-chloropurine-9-yl)(1373313-86-0)

Safety Data

• Hazardous Substances Data: 1373313-86-0(Hazardous Substances Data)

Upstream product

• 1373313-78-0 (1S,4R,5S)-3-[2-(tert-butyldiphenylsilyloxy)ethyl]-4,5-(O-isopropylidenedioxy)cyclopent-2⁽³⁾en-1-ol(1S,4R,5S)-3-[2-(tert-butyldiphenylsilyloxy)ethyl]-4,5-(O-isopropylidenedioxy)cyclopent-2⁽³⁾en-1-ol 
• 87-42-3 6-chloro-7H-purine 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 141436-58-0 (-)-(1R)-1-[(4R,5S)-5-((1S)-1-hydroxyallyl)-2,2-dimethyl[1,3]dioxolan-4-yl]ethane-1,2-diol 
• 67814-68-0 2,3-O-isopropylidene-D-ribofuranose 
• 1373313-77-9 (3aS,4S,6aR)-2,2-dimethyl-6-vinyl-3a,6a-dihydro-4H-cyclopenta[d][1,3]dioxol-4-ol 
• 858360-41-5 (3aS,4S,6aR)-4,6a-dihydro-6-(2-hydroxyethyl)-2,2-dimethyl-3aH-cyclopenta[d][1,3]dioxol-4-ol 

Relevant articles and documents

Structure-Activity Relationships of Neplanocin A Analogues as S -Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities

On the basis of the potent inhibitory activity of neplanocin A (1) against S-adenosylhomocysteine (AdoHcy) hydrolase, we analyzed the comprehensive structure-activity relationships by modifying the adenine and carbasugar moiety of 1 to find the pharmacoph